Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 6,591 | 3,311 | 3,514 | 1,242 | 467 |
| Gross Profit | 6,591 | 3,311 | 3,514 | 1,242 | 467 |
| Operating Expenses | 17,710 | 17,893 | 23,305 | 40,720 | 29,353 |
| Operating Income | -11,118 | -14,581 | -19,791 | -39,478 | -28,886 |
| Other Income | 437 | 539 | 15 | -2,401 | 180 |
| Pre-tax Income | -10,681 | -14,042 | -19,776 | -41,879 | -28,706 |
| Income Tax | 50 | 4 | N/A | N/A | N/A |
| Net Income Continuous | -10,731 | -14,046 | -19,776 | -41,879 | -28,706 |
| Net Income Discontinuous | N/A | 5,809 | -10,155 | N/A | N/A |
| Net Income | $-10,731 | $-8,237 | $-29,931 | $-41,879 | $-28,706 |
| EPS Basic Total Ops | -1.19 | -0.94 | -3.58 | -5.47 | -6.10 |
| EPS Basic Continuous Ops | -1.19 | -1.59 | -2.37 | -5.47 | -6.10 |
| EPS Basic Discontinuous Ops | N/A | 0.66 | -1.22 | N/A | N/A |
| EPS Diluted Total Ops | -1.19 | -0.94 | -3.58 | -5.47 | -6.10 |
| EPS Diluted Continuous Ops | -1.19 | -1.59 | -2.37 | -5.47 | -6.10 |
| EPS Diluted Discontinuous Ops | N/A | 0.66 | -1.22 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.19 | -1.59 | -3.58 | -5.20 | -6.10 |
| EBITDA(a) | $-11,118 | $-14,581 | $-19,791 | $-36,315 | $-27,810 |